Mesoblast Limited
ASX: MSB
Mesoblast Limited is an Australian biopharmaceutical company focused on developing and commercialising therapies based on mesenchymal lineage adult stem cell technology. Its treatment programs target a range of conditions, including cardiovascular disease, orthopedic and spinal disorders, oncology, hematology, as well as immune and inflammatory diseases. Founded b
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Healthcare Pulse Report
A$1200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Healthcare Pulse Report
Stay informed on Australia's healthcare sector with expert research covering healthcare, biotechnology, medical technology, and life sciences companies listed on the ASX.
- ✓ ASX Healthcare & Biotech Research
- ✓ Delivered Fortnightly every 2nd & 4th Tuesday
- ✓ Industry Trends & Risk Analysis
- ✓ Full Historical Report Access
A$1200.00/ 12 months
Risk:High
Subscribe Now →